Literature DB >> 18586335

Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia.

Preethi Premkumar1, Dominic Fannon, Elizabeth Kuipers, Michael A Cooke, Andrew Simmons, Veena Kumari.   

Abstract

The frontal lobe has an extended maturation period and may be vulnerable to the long-term effects of schizophrenia. We tested this hypothesis by studying the relationship between duration of illness (DoI), grey matter (GM) and cerebro-spinal fluid (CSF) volume across the whole brain. Sixty-four patients with schizophrenia and 25 healthy controls underwent structural MRI scanning and neuropsychological assessment. We performed regression analyses in patients to examine the relationship between DoI and GM and CSF volumes across the whole brain, and correlations in controls between age and GM or CSF volume of the regions where GM or CSF volumes were associated with DoI in patients. Correlations were also performed between GM volume in the regions associated with DoI and neuropsychological performance. A longer DoI was associated with lower GM volume in the left dorsomedial prefrontal cortex (PFC), right middle frontal cortex, left fusiform gyrus (FG) and left cerebellum (lobule III). Additionally, age was inversely associated with GM volume in the left dorsomedial PFC in patients, and in the left FG and CSF excess near the left cerebellum in healthy controls. Greater GM volume in the left dorsomedial PFC was associated with better working memory, attention and psychomotor speed in patients. Our findings suggest that the right middle frontal cortex is particularly vulnerable to the long-term effect of schizophrenia illness whereas the dorsomedial PFC, FG and cerebellum are affected by both a long DoI and aging. The effect of illness chronicity on GM volume in the left dorsomedial PFC may be extended to brain structure-neuropsychological function relationships.

Entities:  

Mesh:

Year:  2008        PMID: 18586335     DOI: 10.1016/j.bbr.2008.05.012

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

1.  Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Authors:  Tatsunobu Natsubori; Hideyuki Inoue; Osamu Abe; Yosuke Takano; Norichika Iwashiro; Yuta Aoki; Shinsuke Koike; Noriaki Yahata; Masaki Katsura; Wataru Gonoi; Hiroki Sasaki; Hidemasa Takao; Kiyoto Kasai; Hidenori Yamasue
Journal:  Schizophr Bull       Date:  2013-09-10       Impact factor: 9.306

2.  Grey matter and cognitive deficits in young relatives of schizophrenia patients.

Authors:  Tejas S Bhojraj; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-03-31       Impact factor: 6.556

Review 3.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

4.  Focal and global brain measurements in siblings of patients with schizophrenia.

Authors:  Heleen B M Boos; Wiepke Cahn; Neeltje E M van Haren; Eske M Derks; Rachel M Brouwer; Hugo G Schnack; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2011-01-17       Impact factor: 9.306

5.  Theory of mind and schizophrenia.

Authors:  Rajendra D Badgaiyan
Journal:  Conscious Cogn       Date:  2008-12-13

6.  Three-way (N-way) fusion of brain imaging data based on mCCA+jICA and its application to discriminating schizophrenia.

Authors:  Jing Sui; Hao He; Godfrey D Pearlson; Tülay Adali; Kent A Kiehl; Qingbao Yu; Vince P Clark; Eduardo Castro; Tonya White; Bryon A Mueller; Beng C Ho; Nancy C Andreasen; Vince D Calhoun
Journal:  Neuroimage       Date:  2012-10-26       Impact factor: 6.556

Review 7.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

8.  Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis.

Authors:  Cota Navin Gupta; Vince D Calhoun; Srinivas Rachakonda; Jiayu Chen; Veena Patel; Jingyu Liu; Judith Segall; Barbara Franke; Marcel P Zwiers; Alejandro Arias-Vasquez; Jan Buitelaar; Simon E Fisher; Guillen Fernandez; Theo G M van Erp; Steven Potkin; Judith Ford; Daniel Mathalon; Sarah McEwen; Hyo Jong Lee; Bryon A Mueller; Douglas N Greve; Ole Andreassen; Ingrid Agartz; Randy L Gollub; Scott R Sponheim; Stefan Ehrlich; Lei Wang; Godfrey Pearlson; David C Glahn; Emma Sprooten; Andrew R Mayer; Julia Stephen; Rex E Jung; Jose Canive; Juan Bustillo; Jessica A Turner
Journal:  Schizophr Bull       Date:  2014-12-28       Impact factor: 9.306

9.  [Not Available].

Authors:  Serge A Mitelman; Emily L Canfield; Randall E Newmark; Adam M Brickman; Yuliya Torosjan; King-Wai Chu; Erin A Hazlett; M Mehmet Haznedar; Lina Shihabuddin; Monte S Buchsbaum
Journal:  Open Neuroimag J       Date:  2009-05-20

10.  Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion.

Authors:  Jing Sui; Shile Qi; Theo G M van Erp; Juan Bustillo; Rongtao Jiang; Dongdong Lin; Jessica A Turner; Eswar Damaraju; Andrew R Mayer; Yue Cui; Zening Fu; Yuhui Du; Jiayu Chen; Steven G Potkin; Adrian Preda; Daniel H Mathalon; Judith M Ford; James Voyvodic; Bryon A Mueller; Aysenil Belger; Sarah C McEwen; Daniel S O'Leary; Agnes McMahon; Tianzi Jiang; Vince D Calhoun
Journal:  Nat Commun       Date:  2018-08-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.